Similar HDL-NP mediated inhibition of growth, motility, and metastasis of nasopharyngeal cancer cells have been documented (28) An HDL-NP approach could be explored as a way to target SR-BI expressing neoplastic lymphocytes in canine lymphoma patients. This evidence concerns the gene SCARB1 and lymphoma.